1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Epilepsy Drugs Landscape

4.1 Overview

5. Middle East & Africa Epilepsy Drugs Market - Key Industry Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Epilepsy

5.1.2 Increasing Number of Elderly People

5.2 Market Restraints

5.2.1 Recall of Therapeutic Products

5.3 Market Opportunities

5.3.1 Several Epilepsy Drugs Nearing Patent Expiration

5.4 Future Trends

5.4.1 Increasing Product Approvals

5.5 Impact Analysis

6. Epilepsy Drugs Market - Middle East & Africa Market Analysis

6.1 Middle East & Africa Epilepsy Drugs Market Revenue (US$ Mn), 2022 - 2030

7. Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 - by Treatment

7.1 Overview

7.2 Middle East & Africa Epilepsy Drugs Market Revenue Share, by Treatment 2022 & 2030 (%)

7.3 First Generation Antiepileptics

7.3.1 Overview

7.3.2 First Generation Antiepileptics: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Second Generation Anti-epileptics

7.4.1 Overview

7.4.2 Second Generation Anti-epileptics: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Third Generation Anti-epileptics

7.5.1 Overview

7.5.2 Third Generation Anti-epileptics: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview

8.2 Middle East & Africa Epilepsy Drugs Market Revenue Share, by Distribution Channel 2022 & 2030 (%)

8.3 Hospital Pharmacy

8.3.1 Overview

8.3.2 Hospital Pharmacy: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Retail Pharmacy Stores

8.4.1 Overview

8.4.2 Retail Pharmacy Stores: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Middle East & Africa Epilepsy Drugs Market, by Key Country- Revenue (2022) (US$ Million)

9.1.1.1 South Africa: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.1.1 Overview

9.1.1.1.2 South Africa: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.1.3 South Africa: Middle East & Africa Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.1.4 South Africa: Middle East & Africa Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.1.2 Saudi Arabia: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.2.1 Overview

9.1.1.2.2 Saudi Arabia: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.2.3 Saudi Arabia: Middle East & Africa Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.2.4 Saudi Arabia: Middle East & Africa Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.1.3 UAE: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.3.1 Overview

9.1.1.3.2 UAE: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.3.3 UAE: Middle East & Africa Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.3.4 UAE: Middle East & Africa Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.1.4 Rest of Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.4.1 Overview

9.1.1.4.2 Rest of Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.4.3 Rest of Middle East & Africa Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.4.4 Rest of Middle East & Africa Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Epilepsy Drugs Market-Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Epilepsy Drugs Market

10.3 Inorganic Growth Strategies

10.3.1 Overview

10.4 Organic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Novartis AG

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Pfizer Inc

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 GSK Plc

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Abbott Laboratories

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Sanofi SA

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Teva Pharmaceutical Industries Ltd

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Alkem Laboratories Ltd

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Middle East & Africa Epilepsy Drugs Market Segmentation

Table 2. South Africa: Middle East & Africa Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 3. South Africa: Middle East & Africa Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 4. Saudi Arabia: Middle East & Africa Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 5. Saudi Arabia: Middle East & Africa Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 6. UAE: Middle East & Africa Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 7. UAE: Middle East & Africa Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 8. Rest of Middle East & Africa Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 9. Rest of Middle East & Africa Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 10. Recent Inorganic Growth Strategies in the Epilepsy Drugs Market

Table 11. Recent Organic Growth Strategies in the Epilepsy Drugs Market

Table 12. Glossary of Terms, Middle East & Africa Epilepsy Drugs Market

List of Figures

Figure 1. Middle East & Africa Epilepsy Drugs Market Segmentation, By Country

Figure 2. Middle East & Africa Epilepsy Drugs Market: Key Industry Dynamics

Figure 3. Middle East & Africa Epilepsy Drugs Market: Impact Analysis of Drivers and Restraints

Figure 4. Middle East & Africa Epilepsy Drugs Market Revenue (US$ Mn), 2022 - 2030

Figure 5. Middle East & Africa Epilepsy Drugs Market Revenue Share, by Treatment 2022 & 2030 (%)

Figure 6. First Generation Anti-epileptics: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Second Generation Anti-epileptics: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Third Generation Anti-epileptics: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Middle East & Africa Epilepsy Drugs Market Revenue Share, by Distribution Channel 2022 & 2030 (%)

Figure 10. Hospital Pharmacy: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Retail Pharmacy Stores: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Others: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Middle East & Africa Epilepsy Drugs Market, by Key Country - Revenue (2022) (US$ Million)

Figure 14. Middle East & Africa Epilepsy Drugs Market, by Country, 2022 & 2030 (%)

Figure 15. South Africa: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Saudi Arabia: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. UAE: Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Rest of Middle East & Africa Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Growth Strategies in the Epilepsy Drugs Market